Lessons learned from variation in response to therapy in clinical trials.
about
Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthmaChinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthmaGenetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroidsRole of Leukotrienes and Leukotriene Modifiers in Asthma.A call for action: Comparative effectiveness research in asthma.Advances in pediatric asthma in 2010: addressing the major issuesInnate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonistsPharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues.Advancing asthma care: the glass is only half full!Why aren't we doing better in asthma: time for personalised medicine?An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent AsthmaProstanoids in Asthma and COPD: Actions, Dysregulation, and Therapeutic Opportunities.Stratified approaches to the treatment of asthma.Predictors of response to tiotropium versus salmeterol in asthmatic adults.Role of leukotriene receptor antagonists in the management of pediatric asthma: an update.Addressing corticosteroid insensitivity in adults with asthma.Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.
P2860
Q26771615-4E2A64B5-98B2-4305-9E09-B80E434CF8FEQ26772201-8EEA7F8E-B142-4B9F-BE8D-258110AE1AFFQ28943401-A544FE27-829B-4229-A664-0809D4CB8E7EQ33664150-A8D92194-C6C2-4978-B9BF-A6E2BE11870DQ34474468-3D0F420A-E693-46DA-B371-BFCA8848D1B1Q34545186-0A5FAEBB-7943-44E2-BB23-EC2221858653Q34827999-905187D6-C702-4AC5-AF66-CD8C68D605C8Q35113606-5BC906C1-EB9A-4284-85BF-76AE7AC41CBDQ35190081-CDAB2A83-6EC9-4CA1-8E39-E6CF2D6E42AEQ35216448-B349EAA9-EDF1-478C-BFAC-83518FB54B88Q35534747-BB39DD60-246A-4946-9FD5-D2EC1B40DAF2Q35846993-DE717A5F-E21D-4FCB-9FF4-10F5F4A33B00Q36243240-0FB440B4-055F-463F-9F25-122F6ABFFF54Q37064755-6704A3BD-2E8E-41BA-9060-48F7633B6829Q37303840-BA418305-BD07-4F11-B23C-921BFAB528CCQ38034994-B75D99A2-DF16-41A6-B2DA-C8B9F1F3A3E2Q38930984-7A3B7850-B754-4BB5-9BD5-182CE7B71DFEQ43841288-A959B33B-E436-4611-BA7E-AC6ABFDABF1F
P2860
Lessons learned from variation in response to therapy in clinical trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lessons learned from variation in response to therapy in clinical trials.
@ast
Lessons learned from variation in response to therapy in clinical trials.
@en
type
label
Lessons learned from variation in response to therapy in clinical trials.
@ast
Lessons learned from variation in response to therapy in clinical trials.
@en
prefLabel
Lessons learned from variation in response to therapy in clinical trials.
@ast
Lessons learned from variation in response to therapy in clinical trials.
@en
P2860
P1476
Lessons learned from variation in response to therapy in clinical trials.
@en
P2093
Richard J Martin
P2860
P304
285-92; quiz 293-4
P356
10.1016/J.JACI.2009.10.026
P407
P577
2010-01-13T00:00:00Z